Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines

Vaccine

Volumn 27, Issue 49, 2009, Pages 6939-6949

  Steers, Nicholas J ^a   Peachman, Kristina K ^a   McClain, Sasha ^a   Alving, Carl R ^a   Rao, Mangala ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Effector CD4+ T cells; Liposomal lipid A; Memory CD8+ T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS 1 GAG P24 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPID A; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; ENCAPSULATION; FEMALE; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; LYMPH NODE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPLEEN; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV CORE PROTEIN P24; HIV-1; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LIPID A; LIPOSOMES; LYMPH NODES; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 70350569886     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.105     Document Type: Article

References (73)

1. Belyakov I.M., Isakov D., Zhu Q., Dzutsev A., Klinman D., and Berzofsky J.A. Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host. J Immunol 177 9 (2006) 6336-6343
2. Pichyangkul S., Kum-Arb U., Yongvanitchit K., Limsalakpetch A., Gettayacamin M., Lanar D.E., et al. Preclinical evaluation of the safety and immunogenicity of a vaccine consisting of Plasmodium falciparum liver-stage antigen 1 with adjuvant AS01B administered alone or concurrently with the RTS, /AS01B vaccine in rhesus primates. Infect Immun 76 1 (2008) 229-238
3. Richards R.L., Rao M., Vancott T.C., Matyas G.R., Birx D.L., and Alving C.R. Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen. Immunol Cell Biol 82 5 (2004) 531-538
4. Alving C.R., and Rao M. Lipid A and liposomes containing lipid A as antigens and adjuvants. Vaccine 26 24 (2008) 3036-3045
5. Richards R.L., Swartz Jr. G.M., Schultz C., Hayre M.D., Ward G.S., Ballou W.R., et al. Immunogenicity of liposomal malaria sporozoite antigen in monkeys: adjuvant effects of aluminium hydroxide and non-pyrogenic liposomal lipid A. Vaccine 7 6 (1989) 506-512
6. Fries L.F., Gordon D.M., Richards R.L., Egan J.E., Hollingdale M.R., Gross M., et al. Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. Proc Natl Acad Sci USA 89 1 (1992) 358-362
7. Verma J.N., Rao M., Amselem S., Krzych U., Alving C.R., Green S.J., et al. Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages. Infect Immun 60 6 (1992) 2438-2444
8. Zhou F., and Huang L. Monophosphoryl lipid A enhances specific CTL induction by a soluble protein antigen entrapped in liposomes. Vaccine 11 11 (1993) 1139-1144 javascript:PopUpMenu2_Set(Menu8249434)
9. Alving C.R. Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity. Ann N Y Acad Sci 754 (1995) 143-152
10. Rao M., Wassef N.M., Alving C.R., and Krzych U. Intracellular processing of liposome-encapsulated antigens by macrophages depends upon the antigen. Infect Immun 63 7 (1995) 2396-2402
11. Rao M., Bray M., Alving C.R., Jahrling P., and Matyas G.R. Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells. J Virol 76 18 (2002) 9176-9185
12. Rao M., Matyas G.R., Vancott T.C., Birx D.L., and Alving C.R. Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein. Immunol Cell Biol 82 5 (2004) 523-530
13. Richards R.L., Rao M., Wassef N.M., Glenn G.M., Rothwell S.W., and Alving C.R. Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS, S malaria antigen. Infect Immun 66 6 (1998) 2859-2865
14. Samuel J., Budzynski W.A., Reddish M.A., Ding L., Zimmermann G.L., Krantz M.J., et al. Immunogenicity and antitumor activity of a liposomal MUC1 peptide-based vaccine. Int J Cancer 75 2 (1998) 295-302
15. White W.I., Cassatt D.R., Madsen J., Burke S.J., Woods R.M., Wassef N.M., et al. Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. Vaccine 13 12 (1995) 1111-1122
16. Harding C.V., Collins D.S., Kanagawa O., and Unanue E.R. Liposome-encapsulated antigens engender lysosomal processing for class II MHC presentation and cytosolic processing for class I presentation. J Immunol 147 9 (1991) 2860-2863
17. Rothwell S.W., Wassef N.M., Alving C.R., and Rao M. Proteasome inhibitors block the entry of liposome-encapsulated antigens into the classical MHC class I pathway. Immunol Lett 74 2 (2000) 141-152
18. Peachman K.K., Rao M., Alving C.R., Palmer D.R., Sun W., and Rothwell S.W. Human dendritic cells and macrophages exhibit different intracellular processing pathways for soluble and liposome-encapsulated antigens. Immunobiology 210 5 (2005) 321-333
19. Steers N.J., Alving C.R., and Rao M. Modulation of immunoproteasome subunits by liposomal lipid A. Vaccine 26 23 (2008) 2849-2859
20. Kamath A.T., Rochat A.F., Christensen D., Agger E.M., Andersen P., Lambert P.H., et al. A Liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells. PLoS One 4 6 (2009) e5771
21. Engler O.B., Schwendener R.A., Dai W.J., Wolk B., Pichler W., Moradpour D., et al. A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins. Vaccine 23 1 (2004) 58-68
22. Berenzon D., Schwenk R.J., Letellier L., Guebre-Xabier M., Williams J., and Krzych U. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J Immunol 171 4 (2003) 2024-2034
23. Wiley J.A., Hogan R.J., Woodland D.L., and Harmsen A.G. Antigen-specific CD8(+) T cells persist in the upper respiratory tract following influenza virus infection. J Immunol 167 6 (2001) 3293-3299
24. Reinhardt R.L., Khoruts A., Merica R., Zell T., and Jenkins M.K. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410 6824 (2001) 101-105
25. Jenkins M.R., Kedzierska K., Doherty P.C., and Turner S.J. Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. J Immunol 179 1 (2007) 64-70
26. Raju B., Tung C.F., Cheng D., Yousefzadeh N., Condos R., Rom W.N., et al. In situ activation of helper T cells in the lung. Infect Immun 69 8 (2001) 4790-4798
27. Kaech S.M., Hemby S., Kersh E., and Ahmed R. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111 6 (2002) 837-851
28. Ponta H., Sherman L., and Herrlich P.A. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4 1 (2003) 33-45
29. Wherry E.J., Teichgräber V., Becker T.C., Masopust D., Kaech S.M., Antia R., et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4 3 (2003) 225-234
30. Judge A.D., Zhang X., Fujii H., Surh C.D., and Sprent J. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells. J Exp Med 196 7 (2002) 935-946
31. Dutton R.W., Bradley L.M., and Swain S.L. T cell memory. Annu Rev Immunol 16 (1998) 201-223
32. Kaech S.M., Wherry E.J., and Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2 4 (2002) 251-262
33. Jameson S.C. Maintaining the norm: T-cell homeostasis. Nat Rev Immunol 2 8 (2002) 547-556
34. Mosmann T.R., Schumacher J.H., Street N.F., Budd R., O'Garra A., Fong T.A., et al. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev 123 (1991) 209-229
35. Swain S.L., Huston G., Tonkonogy S., and Weinberg A. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 147 9 (1991) 2991-3000
36. Whitmire J.K., Asano M.S., Murali-Krishna K., Suresh M., and Ahmed R. Long-term CD4 Th1 and Th2 memory following acute lymphocytic choriomeningitis virus infection. J Virol 72 10 (1998) 8281-8288
37. Varga S.M., and Welsh R.M. Detection of a high frequency of virus-specific CD4+ T cells during acute infection with lymphocytic choriomeningitis virus. J Immunol 161 7 (1998) 3215-3218
38. Sun Y., Permar S.R., Buzby A.P., and Letvin N.L. Memory CD4+ T-lymphocyte loss and dysfunction during primary simian immunodeficiency virus infection. J Virol 81 15 (2007) 8009-8015
39. Letvin N.L., Mascola J.R., Sun Y., Gorgone D.A., Buzby A.P., Xu L., et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science 312 5779 (2006) 1530-1533
40. Mattapallil J.J., Douek D.C., Buckler-White A., Montefiori D., Letvin N.L., Nabel G.J., et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J Exp Med 203 6 (2006) 1533-1541
41. Kiepiela P., Ngumbela K., Thobakgale C., Ramduth D., Honeyborne I., Moodley E., et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13 1 (2007) 46-53
42. Rolland M., Heckerman D., Deng W., Rousseau C.M., Coovadia H., Bishop K., et al. Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads. PLoS One 3 (2008) 1424
43. Sathaliyawala T., Rao M., Maclean D.M., Birx D.L., Alving C.R., and Rao V.B. Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines. J Virol 80 15 (2006) 7688-7698
44. Wassef N.M., Alving C.R., and Richards R.L. Liposomes as carriers for vaccines. Immunomethods 4 3 (1994) 217-222
45. Alving C.R., Shichijo S., Mattsby-Baltzer I., Richards R.L., and Wassef N.M. Preparation and use of liposomes in immunological studies. In: Gregoriadis G. (Ed). Liposome Technology vol. 3 (1993), CRC press Inc., Boca Raton, FL 317-343
46. Xu J., Huang X., Qui C., Liu Y., Liu Y., and Shao Y. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes. AIDS 20 18 (2006) 2293-2303
47. Rao M., Rothwell S.W., Wassef N.M., Pagano R.E., and Alving C.R. Visualization of peptides derived from liposome-encapsulated proteins in the trans-Golgi area of macrophages. Immunol Lett 59 2 (1997) 99-105
48. Flynn K.J., Belz G.T., Altman J.D., Ahmed R., Woodland D.L., and Doherty P.C. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8 6 (1998) 683-691
49. Turner S.J., Kedzierska K., La Gruta N.L., Webby R., and Doherty P.C. Characterization of CD8+ T cell repertoire diversity and persistence in the influenza A virus model of localized, transient infection. Semin Immunol 16 3 (2004) 179-184
50. Lefrançois L., Marzo A.L., Masopust D., Schluns K.S., and Vezy V. Migration of primary and memory CD8 T cells. Adv Exp Med Biol 512 (2002) 141-146
51. Lefrançois L., and Masopust D. T cell immunity in lymphoid and non-lymphoid tissues. Curr Opin Immunol 14 4 (2002) 503-508
52. Lefrançois L. Development, trafficking, and function of memory T-cell subsets. Immunol Rev 211 (2006) 93-103
53. Belz G.T., Wodarz D., Diaz G., Nowak M.A., and Doherty P.C. Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice. J Virol 76 23 (2002) 12388-12393
54. Janssen E.M., Lemmens E.E., Wolfe T., Christen U., von Herrath M.G., and Schoenberger S.P. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421 6925 (2003) 852-856
55. Sun J.C., and Bevan M.J. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300 5617 (2003) 339-342
56. Sun J.C., Williams M.A., and Bevan M.J. CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection. Nat Immunol 5 9 (2004) 927-933
57. Ramsburg E.A., Publicover J.M., Coppock D., and Rose J.K. Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent. J Immunol 178 10 (2007) 6350-6358
58. Resende D.M., Caetano B.C., Dutra M.S., Penido M.L., Abrantes C.F., Verly R.M., et al. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells. Vaccine 26 35 (2008) 4585-4593
59. Kamath A.T., Valenti M.P., Rochat A.F., Agger E.M., Lingnau K., von Gabain A., et al. Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cells. Eur J Immunol 38 5 (2008) 1247-1256
60. Leligdowicz A., Yindom L.M., Onyango C., Sarge-Njie R., Alabi A., Cotten M., et al. Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. J Clin Invest 117 10 (2007) 3067-3074
61. Horton H., Frank I., Baydo R., Jalbert E., Penn J., Wilson S., et al. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J Immunol 177 10 (2006) 7406-7415
62. Steers N.J., Peachman K.K., McClain S., Alving C.R., and Rao M. Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation. J Virol 83 14 (2009) 7049-7061
63. Mullbacher A. The long-term maintenance of cytotoxic T cell memory does not require persistence of antigen. J Exp Med 179 1 (1994) 317-321
64. Kedzierska K., Stambas J., Jenkins M.R., Keating R., Turner S.J., and Doherty P.C. Location rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory. Proc Natl Acad Sci USA 104 23 (2007) 9782-9787
65. Jones S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175 6 (2005) 3463-3468
66. Longhi M.P., Wright K., Lauder S.N., Nowell M.A., Jones G.W., Godkin A.J., et al. Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog 4 2 (2008)
67. Randolph G.J., Inaba K., Robbiani D.F., Steinman R.M., and Muller W.A. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11 6 (1999) 753-761
68. Palframan R.T., Jung S., Cheng G., Weninger W., Luo Y., Dorf M., et al. Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 194 9 (2001) 1361-1373
69. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19 (2001) 683-765
70. Morel A.S., Quaratino S., Douek D.C., and Londei M. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur J Immunol 27 1 (1997) 26-34
71. Förtsch D., Röllinghoff M., and Stenger S. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J Immunol 165 2 (2000) 978-987
72. Allavena P., Piemonti L., Longoni D., Bernasconi S., Stoppacciaro A., Ruco L., et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 28 1 (1998) 359-369
73. Mescher M.F., Agarwal P., Casey K.A., Hammerbeck C.D., Xiao Z., and Curtsinger J.M. Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation. Semin Immunol 19 3 (2007) 153-161